List of Tables
Table 1. Global Pulmonary Disease Aerosol Delivery Devices Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pulmonary Disease Aerosol Delivery Devices Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pulmonary Disease Aerosol Delivery Devices Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pulmonary Disease Aerosol Delivery Devices Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pulmonary Disease Aerosol Delivery Devices Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pulmonary Disease Aerosol Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pulmonary Disease Aerosol Delivery Devices, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pulmonary Disease Aerosol Delivery Devices, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pulmonary Disease Aerosol Delivery Devices, Product Types and Applications
Table 12. Global Key Manufacturers of Pulmonary Disease Aerosol Delivery Devices, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pulmonary Disease Aerosol Delivery Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pulmonary Disease Aerosol Delivery Devices Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pulmonary Disease Aerosol Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (K Units), 2021–2026
Table 18. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Region (2021–2026)
Table 19. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (K Units), 2027–2032
Table 20. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Region (2027–2032)
Table 21. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region (2021–2026)
Table 23. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region (2027–2032)
Table 25. North America Pulmonary Disease Aerosol Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2021–2026
Table 27. North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2027–2032
Table 28. North America Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2021–2026
Table 32. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2027–2032
Table 33. Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pulmonary Disease Aerosol Delivery Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pulmonary Disease Aerosol Delivery Devices Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pulmonary Disease Aerosol Delivery Devices Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pulmonary Disease Aerosol Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2021–2026
Table 42. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2027–2032
Table 43. Latin America Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units) by Type (2021–2026)
Table 51. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units) by Type (2027–2032)
Table 52. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Type (2021–2026)
Table 53. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Type (2027–2032)
Table 54. Global Pulmonary Disease Aerosol Delivery Devices Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pulmonary Disease Aerosol Delivery Devices Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Type (2021–2026)
Table 57. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Type (2027–2032)
Table 58. Global Pulmonary Disease Aerosol Delivery Devices Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pulmonary Disease Aerosol Delivery Devices Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units) by Application (2021–2026)
Table 61. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units) by Application (2027–2032)
Table 62. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Application (2021–2026)
Table 63. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Application (2027–2032)
Table 64. Global Pulmonary Disease Aerosol Delivery Devices Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pulmonary Disease Aerosol Delivery Devices Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Application (2021–2026)
Table 67. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Application (2027–2032)
Table 68. Global Pulmonary Disease Aerosol Delivery Devices Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pulmonary Disease Aerosol Delivery Devices Price (US$/Unit) by Application (2027–2032)
Table 70. GlaxoSmithKline (GSK) Company Information
Table 71. GlaxoSmithKline (GSK) Description and Business Overview
Table 72. GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Product
Table 74. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Pulmonary Disease Aerosol Delivery Devices Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Mylan Company Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Mylan Pulmonary Disease Aerosol Delivery Devices Product
Table 89. Mylan Recent Developments/Updates
Table 90. Viatris Company Information
Table 91. Viatris Description and Business Overview
Table 92. Viatris Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Viatris Pulmonary Disease Aerosol Delivery Devices Product
Table 94. Viatris Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novartis Pulmonary Disease Aerosol Delivery Devices Product
Table 99. Novartis Recent Developments/Updates
Table 100. AptarGroup Company Information
Table 101. AptarGroup Description and Business Overview
Table 102. AptarGroup Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AptarGroup Pulmonary Disease Aerosol Delivery Devices Product
Table 104. AptarGroup Recent Developments/Updates
Table 105. Chiesi Farmaceutici Company Information
Table 106. Chiesi Farmaceutici Description and Business Overview
Table 107. Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Product
Table 109. Chiesi Farmaceutici Recent Developments/Updates
Table 110. Koninklijke Philips Company Information
Table 111. Koninklijke Philips Description and Business Overview
Table 112. Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Product
Table 114. Koninklijke Philips Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Company Information
Table 116. Teva Pharmaceutical Industries Description and Business Overview
Table 117. Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Product
Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
Table 120. Monaghan Medical Company Information
Table 121. Monaghan Medical Description and Business Overview
Table 122. Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Product
Table 124. Monaghan Medical Recent Developments/Updates
Table 125. OMRON Company Information
Table 126. OMRON Description and Business Overview
Table 127. OMRON Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. OMRON Pulmonary Disease Aerosol Delivery Devices Product
Table 129. OMRON Recent Developments/Updates
Table 130. PARI International Company Information
Table 131. PARI International Description and Business Overview
Table 132. PARI International Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. PARI International Pulmonary Disease Aerosol Delivery Devices Product
Table 134. PARI International Recent Developments/Updates
Table 135. Vectura Company Information
Table 136. Vectura Description and Business Overview
Table 137. Vectura Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Vectura Pulmonary Disease Aerosol Delivery Devices Product
Table 139. Vectura Recent Developments/Updates
Table 140. H&T Presspart Company Information
Table 141. H&T Presspart Description and Business Overview
Table 142. H&T Presspart Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. H&T Presspart Pulmonary Disease Aerosol Delivery Devices Product
Table 144. H&T Presspart Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pulmonary Disease Aerosol Delivery Devices Distributors List
Table 148. Pulmonary Disease Aerosol Delivery Devices Customers List
Table 149. Pulmonary Disease Aerosol Delivery Devices Market Trends
Table 150. Pulmonary Disease Aerosol Delivery Devices Market Drivers
Table 151. Pulmonary Disease Aerosol Delivery Devices Market Challenges
Table 152. Pulmonary Disease Aerosol Delivery Devices Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pulmonary Disease Aerosol Delivery Devices
Figure 2. Global Pulmonary Disease Aerosol Delivery Devices Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pulmonary Disease Aerosol Delivery Devices Market Share by Type: 2025 & 2032
Figure 4. Metered- dose Inhalers Product Picture
Figure 5. Dry-powder Inhalers Product Picture
Figure 6. Nebulizers Product Picture
Figure 7. Global Pulmonary Disease Aerosol Delivery Devices Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Pulmonary Disease Aerosol Delivery Devices Market Share by Application: 2025 & 2032
Figure 9. Asthma
Figure 10. Chronic Obstructive Pulmonary Disease (COPD)
Figure 11. Cystic Fibrosis (CF)
Figure 12. Idiopathic Pulmonary Fibrosis (IPF)
Figure 13. Others
Figure 14. Global Pulmonary Disease Aerosol Delivery Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Pulmonary Disease Aerosol Delivery Devices Market Size (US$ Million), 2021–2032
Figure 16. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units), 2021–2032
Figure 17. Global Pulmonary Disease Aerosol Delivery Devices Average Price (US$/Unit), 2021–2032
Figure 18. Pulmonary Disease Aerosol Delivery Devices Report Years Considered
Figure 19. Pulmonary Disease Aerosol Delivery Devices Sales Share by Manufacturers in 2025
Figure 20. Global Pulmonary Disease Aerosol Delivery Devices Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Pulmonary Disease Aerosol Delivery Devices Players: Market Share by Revenue in Pulmonary Disease Aerosol Delivery Devices in 2025
Figure 22. Pulmonary Disease Aerosol Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Pulmonary Disease Aerosol Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021–2032)
Figure 25. North America Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 26. United States Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021–2032)
Figure 29. Europe Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 30. Germany Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region (2021–2032)
Figure 37. China Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021–2032)
Figure 45. Latin America Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Pulmonary Disease Aerosol Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Pulmonary Disease Aerosol Delivery Devices by Type (2021–2032)
Figure 56. Global Revenue Market Share of Pulmonary Disease Aerosol Delivery Devices by Type (2021–2032)
Figure 57. Global Pulmonary Disease Aerosol Delivery Devices Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Pulmonary Disease Aerosol Delivery Devices by Application (2021–2032)
Figure 59. Global Revenue Market Share of Pulmonary Disease Aerosol Delivery Devices by Application (2021–2032)
Figure 60. Global Pulmonary Disease Aerosol Delivery Devices Price (US$/Unit) by Application (2021–2032)
Figure 61. Pulmonary Disease Aerosol Delivery Devices Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
